AADI logo

Aadi Bioscience (AADI)

Profile

Full Name

Whitehawk Therapeutics, Inc.

Ticker Symbol

AADI

Exchange

NASDAQ

Country

United States

IPO

February 16, 2018

Indexes

Not included

Employees

53

Key Details

Price

$1.64(+1.23%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$25.98M(+6.69% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Aug 27, 24 Piper Sandler
Neutral
Aug 21, 24 TD Cowen
Hold
Aug 21, 24 HC Wainwright & Co.
Neutral
May 14, 24 HC Wainwright & Co.
Neutral
Dec 15, 23 Piper Sandler
Overweight
Dec 15, 23 HC Wainwright & Co.
Neutral
Nov 13, 23 HC Wainwright & Co.
Buy
Aug 10, 23 HC Wainwright & Co.
Buy
Jun 8, 23 HC Wainwright & Co.
Buy
May 17, 23 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Aadi Bioscience?
  • Does Aadi Bioscience pay dividends?
  • What sector is Aadi Bioscience in?
  • What industry is Aadi Bioscience in?
  • What country is Aadi Bioscience based in?
  • When did Aadi Bioscience go public?
  • Is Aadi Bioscience in the S&P 500?
  • Is Aadi Bioscience in the NASDAQ 100?
  • Is Aadi Bioscience in the Dow Jones?
  • When was Aadi Bioscience's last earnings report?
  • When does Aadi Bioscience report earnings?
  • Should I buy Aadi Bioscience stock now?

What is the ticker symbol for Aadi Bioscience?

The ticker symbol for Aadi Bioscience is NASDAQ:AADI

Does Aadi Bioscience pay dividends?

No, Aadi Bioscience does not pay dividends

What sector is Aadi Bioscience in?

Aadi Bioscience is in the Healthcare sector

What industry is Aadi Bioscience in?

Aadi Bioscience is in the Biotechnology industry

What country is Aadi Bioscience based in?

Aadi Bioscience is headquartered in United States

When did Aadi Bioscience go public?

Aadi Bioscience's initial public offering (IPO) was on February 16, 2018

Is Aadi Bioscience in the S&P 500?

No, Aadi Bioscience is not included in the S&P 500 index

Is Aadi Bioscience in the NASDAQ 100?

No, Aadi Bioscience is not included in the NASDAQ 100 index

Is Aadi Bioscience in the Dow Jones?

No, Aadi Bioscience is not included in the Dow Jones index

When was Aadi Bioscience's last earnings report?

Aadi Bioscience's most recent earnings report was on Mar 20, 2025

When does Aadi Bioscience report earnings?

The date for Aadi Bioscience's next earnings report has not been announced yet

Should I buy Aadi Bioscience stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page